JUST IN
You are here » Home » Company » Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd.

BSE: 532296 Sector: Health care
NSE: GLENMARK ISIN Code: INE935A01035
BSE 00:00 | 18 Jan 640.85 -20.35
(-3.08%)
OPEN

659.50

 HIGH

659.50

 LOW

635.25
NSE 00:00 | 18 Jan 640.40 -21.10
(-3.19%)
OPEN

659.90

 HIGH

663.00

 LOW

635.00
Add to Watchlist  |   Add to Portfolio
OPEN 659.50
PREVIOUS CLOSE 661.20
VOLUME 39020
52-Week high 711.55
52-Week low 483.60
P/E 14.01
Mkt Cap.(Rs cr) 18,085
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 659.50
CLOSE 661.20
VOLUME 39020
52-Week high 711.55
52-Week low 483.60
P/E 14.01
Mkt Cap.(Rs cr) 18,085
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd is a research-driven global integrated pharmaceutical company. The company is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology Respiratory and Dermatology. Its branded...> More

Glenmark Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   18,085
EPS - TTM () [*S] 45.75
P/E Ratio (X) [*S] 14.01
Face Value ()   1
Latest Dividend (%)   200.00
Latest Dividend Date 19 Sep 2018
Dividend Yield (%) 0.31
Book Value / Share () [*S] 408.80
P/B Ratio () [*S] 1.57
[*C] Consolidated     [*S] Standalone    

News

Announcement

Glenmark Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Sep 2018 Sep 2017 % Chg
Net Sales 2581.34 2256.59 14.39
Other Income 307.06 29.73 932.83
Total Income 2888.39 2286.32 26.33
Total Expenses 2141.23 1868.19 14.62
Operating Profit 747.17 418.12 78.7
Net Profit 414 214.12 93.35
Equity Capital 28.22 28.22 -
> More on Glenmark Pharmaceuticals Ltd Financials Results

Glenmark Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Torrent Pharma. 1896.05 0.46 32084.96
Glaxosmi. Pharma 1417.50 -1.45 24013.87
Alkem Lab 1902.30 0.69 22742.00
Glenmark Pharma. 640.85 -3.08 18084.79
Abbott India 8072.60 -1.39 17154.28
Sanofi India 6369.80 0.09 14669.65
Natco Pharma 685.05 -1.10 12649.45
> More on Glenmark Pharmaceuticals Ltd Peer Group

Glenmark Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 46.54
Banks/FIs 2.82
FIIs 30.90
Insurance 0.00
Mutual Funds 4.28
Indian Public 9.81
Custodians 0.00
Other 5.47
> More on Glenmark Pharmaceuticals Ltd Share Holding Pattern

Glenmark Pharmaceuticals Ltd - Research Reports

Date Broker Action Price Report
03/05 HDFC Securities Buy 894 PDF IconDetails
> More on Glenmark Pharmaceuticals Ltd Research Reports

Glenmark Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -1.70% -1.67% 1.05% 1.04%
1 Month -6.69% -6.66% 0.11% -0.02%
3 Month 6.81% 6.79% 4.62% 4.34%
6 Month 15.53% 15.23% 0.04% -0.67%
1 Year 2.53% 2.34% 3.19% 0.83%
3 Year -16.20% -16.22% 50.43% 48.37%

Glenmark Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 635.25
659.50
Week Low/High 635.25
675.00
Month Low/High 635.25
707.00
YEAR Low/High 483.60
712.00
All TIME Low/High 1.89
1262.00

Browse STOCK Companies

Quick Links for Glenmark Pharmaceuticals: